Literature DB >> 18248262

Sleep in zebrafish.

Irina V Zhdanova1.   

Abstract

Zebrafish (Danio rerio), a small prolific rapidly-developing diurnal vertebrate, shows behavioral, physiological, and pharmacological characteristics of mammalian sleep. Zebrafish brain has well-developed neuronal structures and neurochemical systems that are known to be necessary and sufficient for sleep regulation in other vertebrate species. Rich behavioral repertoire in zebrafish permits investigation of the effects of sleep and sleep deprivation on cognitive functions and performance. Sensitivity of this fish to hypnotic agents helps in designing high throughput screens for new hypnotic medications, evaluation of their efficacy, and potential side effects. The optical transparency of larval zebrafish and intracellular fluorescent markers of calcium responses available make it possible to visualize neuronal activity with single cell resolution in a behaving fish. Given the accumulated experience in conducting large-scale genetic screens in zebrafish, multiple available mutant phenotypes, and advanced genetic and physical maps of this vertebrate, zebrafish is an excellent model for studying the enigmatic basic sleep function and mechanisms of sleep regulation.

Entities:  

Year:  2006        PMID: 18248262     DOI: 10.1089/zeb.2006.3.215

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  26 in total

1.  Activity Suppression Behavior Phenotype in SULT4A1 Frameshift Mutant Zebrafish.

Authors:  Frank Crittenden; Holly R Thomas; John M Parant; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2015-05-01       Impact factor: 3.922

Review 2.  Sleep and Development in Genetically Tractable Model Organisms.

Authors:  Matthew S Kayser; David Biron
Journal:  Genetics       Date:  2016-05       Impact factor: 4.562

Review 3.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 4.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

5.  Shoaling develops with age in Zebrafish (Danio rerio).

Authors:  Christine Buske; Robert Gerlai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-09-15       Impact factor: 5.067

6.  Mammalian sleep dynamics: how diverse features arise from a common physiological framework.

Authors:  Andrew J K Phillips; Peter A Robinson; David J Kedziora; Romesh G Abeysuriya
Journal:  PLoS Comput Biol       Date:  2010-06-24       Impact factor: 4.475

Review 7.  Adult zebrafish as a model organism for behavioural genetics.

Authors:  William Norton; Laure Bally-Cuif
Journal:  BMC Neurosci       Date:  2010-08-02       Impact factor: 3.288

Review 8.  Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond.

Authors:  Allan V Kalueff; Michael Gebhardt; Adam Michael Stewart; Jonathan M Cachat; Mallorie Brimmer; Jonathan S Chawla; Cassandra Craddock; Evan J Kyzar; Andrew Roth; Samuel Landsman; Siddharth Gaikwad; Kyle Robinson; Erik Baatrup; Keith Tierney; Angela Shamchuk; William Norton; Noam Miller; Teresa Nicolson; Oliver Braubach; Charles P Gilman; Julian Pittman; Denis B Rosemberg; Robert Gerlai; David Echevarria; Elisabeth Lamb; Stephan C F Neuhauss; Wei Weng; Laure Bally-Cuif; Henning Schneider
Journal:  Zebrafish       Date:  2013-03       Impact factor: 1.985

9.  Aging of the circadian system in zebrafish and the effects of melatonin on sleep and cognitive performance.

Authors:  I V Zhdanova; L Yu; M Lopez-Patino; E Shang; S Kishi; E Guelin
Journal:  Brain Res Bull       Date:  2007-11-21       Impact factor: 4.077

10.  Why we sleep: the temporal organization of recovery.

Authors:  Emmanuel Mignot
Journal:  PLoS Biol       Date:  2008-04-29       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.